We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
Cap. Flow
-$78.4M
Cap. Flow %
-9.07%
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299

Top Buys

Rank Stock Value
1
XP icon
XP
XP
+$7.27M
2
STZ icon
Constellation Brands
STZ
+$7.01M
3
LLY icon
Eli Lilly
LLY
+$6.9M
4
ADP icon
Automatic Data Processing
ADP
+$6.79M
5
NU icon
Nu Holdings
NU
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Healthcare 18.49%
3 Consumer Discretionary 15.79%
4 Industrials 10.31%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTDR icon
151
Frontdoor
FTDR
$5.1B
$1.66M 0.19%
47,101
+15,219
+48% +$506K
FCX icon
152
Freeport-McMoran
FCX
$90B
$1.64M 0.19%
+38,528
New +$1.42M
VEEV icon
153
Veeva Systems
VEEV
$33.1B
$1.64M 0.19%
8,515
+5,501
+183% +$1.04M
NVCR icon
154
NovoCure
NVCR
$1.73B
$1.63M 0.19%
109,432
-28,289
-21% -$379K
LULU icon
155
lululemon athletica
LULU
$13.5B
$1.63M 0.19%
3,192
+669
+27% +$289K
HESM icon
156
Hess Midstream
HESM
$5.24B
$1.63M 0.19%
+51,591
New +$1.58M
NOVA
157
DELISTED
Sunnova Energy
NOVA
$1.63M 0.19%
106,612
-28,948
-21% -$317K
EFX icon
158
Equifax
EFX
$20.3B
$1.62M 0.19%
6,555
-2,635
-29% -$534K
IART icon
159
Integra LifeSciences
IART
$1.29B
$1.61M 0.19%
+37,081
New +$1.46M
AN icon
160
AutoNation
AN
$7.11B
$1.61M 0.19%
10,689
+6,914
+183% +$954K
PBR.A icon
161
Petrobras Class A
PBR.A
$111B
$1.6M 0.19%
104,751
+57,990
+124% +$831K
EAT icon
162
Brinker International
EAT
$9.17B
$1.59M 0.18%
+36,917
New +$1.33M
SYK icon
163
Stryker
SYK
$125B
$1.59M 0.18%
+5,317
New +$1.49M
M icon
164
Macy's
M
$6.53B
$1.57M 0.18%
+77,926
New +$1.13M
CRDO icon
165
Credo Technology Group
CRDO
$38.6B
$1.56M 0.18%
80,313
-53,177
-40% -$904K
ALV icon
166
Autoliv
ALV
$9.02B
$1.56M 0.18%
+14,183
New +$1.41M
GPI icon
167
Group 1 Automotive
GPI
$3.42B
$1.56M 0.18%
+5,125
New +$1.4M
DNLI icon
168
Denali Therapeutics
DNLI
$3.65B
$1.56M 0.18%
+72,587
New +$1.44M
CRH icon
169
CRH
CRH
$63.2B
$1.56M 0.18%
+22,512
New +$1.36M
SWTX
170
DELISTED
SpringWorks Therapeutics
SWTX
$1.54M 0.18%
+42,303
New +$1.1M
HOOD icon
171
Robinhood
HOOD
$77.8B
$1.53M 0.18%
120,072
+106,677
+796% +$1.06M
EMN icon
172
Eastman Chemical
EMN
$8B
$1.53M 0.18%
16,999
+6,321
+59% +$504K
ALGN icon
173
Align Technology
ALGN
$12.1B
$1.52M 0.18%
5,563
+1,900
+52% +$450K
UBS icon
174
UBS Group
UBS
$173B
$1.52M 0.18%
+49,181
New +$1.29M
DHT icon
175
DHT Holdings
DHT
$2.99B
$1.51M 0.17%
153,600
+65,129
+74% +$670K

Similar funds

Seven Eight Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.

  • Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
  • Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
  • Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
  • Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
  • Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
  • Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
  • Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.

Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.